Tris Pharma receives USFDA approval for ONYDA XR, a liquid non-stimulant ADHD medication
ONYDA XR is indicated for the treatment of ADHD as monotherapy or as adjunctive therapy to approved CNS stimulant medications in…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.